Výsledky vyhledávání - "S. Sterikoff"

A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group)

Autor: S. Sterikoff, Gary R. Erdmann, Bruce Bostrom, Bruce M. Camitta, J J Shuster, G.N. Brockway, Beverly Bell

Publikováno v: Pediatric Blood & Cancer. 43:105-109

Introduction. Mercaptopurine is an important antimetabolite for treatment of childhood acute lymphoblastic leukemia (ALL). It has been prescribed to be given daily without therapeutic monitoring of drug levels. After first-pass metabolism by hepatic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d2ba925567989330d2aaf0f62d09fd
https://doi.org/10.1002/pbc.20089

Zobrazit plný text záznamu

A Comparison of Hepatotoxicity and Neutropenia in Children Given Oral Mercaptopurine on a Twice-Daily Versus Once-Daily Dosing Schedule for Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study

Autor: Bruce Bostrom, Gary R. Erdmann, R. Chesley, Bruce M. Camitta, S. Sterikoff, Meenakshi Devidas, Beverly Bell

Publikováno v: Blood. 104:994-994

Pediatric Oncology Group (POG) protocol 9605, a phase III study of standard risk acute lymphoblastic leukemia (ALL), was designed in part to compare daily (QD) versus twice-daily (BID) mercaptopurine (MP) dosing during intensification and continuatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb1e6db12c153be32a020f3479993eb1
https://doi.org/10.1182/blood.v104.11.994.994

Zobrazit plný text záznamu

Utility of end consolidation bone marrow aspirates in childhood acute lymphoblastic leukemia [ALL]: A Pediatric Oncology Group study [POG]

Autor: S. Sterikoff, K. J. Hull, B. B. Bell, Joanne Kurtzberg, Bruce M. Camitta, Meenakshi Devidas, Allen R. Chauvenet

Publikováno v: Journal of Clinical Oncology. 22:8564-8564

8564 Background: There is little information on the value of bone marrow aspirates (BMA) as a guide to treatment in pediatric ALL. Although BMA morphology provides useful information at diagnosis, end of induction, and end of therapy, its value when

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d3b434b66ef2a936f5c657534acc927
https://doi.org/10.1200/jco.2004.22.90140.8564

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání